Anchiano Therapeutics Ltd. announced the appointments of Stephen Hoffman, M.D., Ph.D. as Chairman and Robert Connelly as Director to its Board of Directors. Dr. Hoffman has served for over two decades as a Chief Executive Officer, board member, advisor and investment manager in the biopharmaceutical sector. Mr. Connelly has over 18 years of experience as a Chief Executive Officer and in starting, financing, building and leading innovative biotechnology companies. Dr. Hoffman currently serves as Chief Executive Officer of Aerpio Pharmaceuticals Inc. Prior to that, he served as Senior Advisor of PDL BioPharma Inc. Dr. Hoffman currently serves on the Board of Directors of Dicerna Pharmaceuticals Inc., and AcelRx Pharmaceuticals Inc. Mr. Connelly is a seasoned biotech executive having served in senior management roles, including CEO and Board member, for several biotechnology companies. Most recently, Mr. Connelly was a Venture Partner with Flagship Pioneering. During this same time, Mr. Connelly was Chief Executive Officer of Axcella Health Inc.